Gennex Laboratories Limited (BOM:531739)
12.07
-0.50 (-3.98%)
At close: May 9, 2025
Gennex Laboratories Company Description
Gennex Laboratories Limited engages in manufacturing and selling of bulk drugs, intermediates, and biotech products.
The company offers Guaifenesin, Methocarbamol, Fexifenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl, and Allopurinol.
It operates in India, Colombia, Egypt, Germany, Iran, Peru, Saudi Arabia, Spain, Thailand, and Vietnam.
The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Gennex Laboratories Limited
Country | India |
Founded | 1990 |
Industry | Pharmaceutical Preparations |
Employees | 129 |
CEO | Arihant Baid |
Contact Details
Address: Plot No. 144, Akash Ganga Complex Hyderabad, 500 073 India | |
Phone | 91 40 6733 4400 |
Website | gennexlab.com |
Stock Details
Ticker Symbol | 531739 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Arihant Baid | Chief Executive Officer |
Akkali Kumar | Chief Financial Officer |
K. V. L. Bhaswanth | Chief Operating Officer |